Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Condensed Consolidated Statements of Operations
Revenue	$ 0	$ 0
Operating expenses:
Research and development	5,607	5,008
General and administrative	7,402	5,401
Loss from operations	(13,009)	(10,409)
Other income/(expense):
Unrealized gain/(loss) on derivatives (Note 5)	0	167
Amortization expense	(64)	0
Other income/(loss)	(17)	6
Net interest income	315	348
Total other income/(loss), net	234	521
Net loss	$ (12,775)	$ (9,888)
Loss per common share, basic and diluted	$ (0.64)	$ (0.52)
Weighted-average number of common shares outstanding basic and diluted (Note 3)	19,896	18,942